19Mar 2023
Additional malignancies and mortality in uveal melanoma: A 20‐year follow‐up

Additional malignancies and mortality in uveal melanoma: A 20‐year follow‐up

This study aims to explore the frequency of additional primary malignancies in uveal melanoma (UM) patients and cause‐specific mortality, to help guide surveillance strategies after UM. The study population included 960 UM patients: 77% were diagnosed with stage I/II, and 56% were men. The mean age at diagnosis was 63 years. The study results in support that UM patients frequently have additional malignancies, both before and after UM. Low UM mortality in patients with a primary malignancy after UM might indicate less aggressive UM. The cumulative UM mortality flattens about ten years after diagnosis, and annual follow‐up of patients for ten years seems adequate.

  • #ophthalmology

Like

Save

Share